Validated phytochemical assessment models tailored to Korea's Health Functional Food standards and K-Beauty cosmeceutical regulations.
Quantifying seasonal and regional variations of bioactive markers to satisfy Korean MFDS Individually Recognized Raw Material benchmarks.
ODM Potency Study Details
Targeted anti-inflammatory, tyrosinase inhibition, and skin-barrier bioassays supporting functional cosmeceutical claims in Seoul markets.
OEM In Vitro Test Suite
Precision HPLC/HPTLC mapping across harvest cycles, eliminating batch variance for high-end Korean dietary health manufacturers.
Harvest Optimization Service
Metabolic, cognitive, and immune response animal models designed to fulfill Korean statutory toxicological assessment protocols.
OEM Animal Study ProtocolThe Republic of Korea stands as one of the world's most sophisticated and demanding environments for natural raw materials. Driven by rigorous statutory frameworks overseen by the Ministry of Food and Drug Safety (MFDS, 식품의약품안전처), Korean enterprises operating in the functional food, cosmetic (K-Beauty), and natural pharmaceutical domains require far more than generic herbal powders.
South Korea's Health Functional Foods (건강기능식품) Act mandates exhaustive chromatographic substantiation for "Individually Recognized Functional Ingredients" (개별인정형 원료). Under this regime, procurement and formulation executives cannot rely solely on dry-weight extract ratios (e.g., 10:1 or 20:1). They demand exact quantification of secondary marker metabolites—such as specific ginsenoside fractions, polyphenolic glycosides, triterpenic acids, and specialized bioflavonoids—accompanied by definitive toxicity and bio-potency profiles.
HPTLC and HPLC chromatographic fingerprinting matching target botanicals against reference chromatograms to eliminate botanical adulteration.
Seasonal harvest tracking across pristine microclimates, establishing optimal phytochemical accumulation curves.
Acute oral LD50, Ames genotoxicity, and chronic organ toxicity profiles pre-cleared for smooth regulatory dossier approval.
The natural medicine and functional ingredient sector has evolved from empirical traditional recipes into an exact, molecularly verified science governed by international consensus.
Traditional single-marker assay titration is rapidly being superseded by high-resolution multi-metabolite profiling. Enterprise buyers across Korea, Japan, and the EU demand holistic chromatographic patterns that preserve the natural phytocomplex entourage effect while fixing active marker percentages within strict ±2% tolerances.
Driven by stringent ESG initiatives and global clean-label demands, procurement programs are phasing out toxic petrochemical solvent fractions (e.g., chlorinated alkanes, hexane). Subcritical water extraction, bio-ethanol cycles, and supercritical CO2 extraction have become standard prerequisite requirements for tier-1 brand consideration.
Suppliers must demonstrate immutable end-to-end provenance. From DNA barcoding that certifies botanical species identity at the farm gate to localized meteorological logging during cultivation, multinational procurement teams require complete traceability data packages to eliminate adulteration risks.
The modern botanical manufacturing complex operated by MedGence (Yineng Pharma) in Changsha, Hunan, exemplifies the next frontier of phytopharmaceutical Industry 4.0 engineering. By integrating automated continuous countercurrent extraction towers, real-time NIR (Near-Infrared) spectroscopic in-line monitoring, and PLC-controlled multi-stage nanofiltration membranes, we ensure that batch processing transitions seamlessly from pilot trials to multi-ton commercial orders.
For Korean enterprise buyers, this automated manufacturing paradigm delivers an unbeatable value proposition: exceptional batch-to-batch homogeneity, drastically compressed production cycles, and aggressive unit cost efficiencies achieved through thermodynamic solvent recycling and high extraction yields.
Algorithmic parameter tuning (temperature gradients, ultrasonic frequency, solvent polarity) yields 18–34% higher active purity compared to conventional static maceration.
Direct agricultural GAP cooperative networks covering over 40 geo-authentic cultivation bases across China guarantee raw botanical reserve stability regardless of seasonal climate anomalies.
Korean partners maintain absolute intellectual property ownership. Proprietary client extraction protocols, customized fractions, and finished formulations are guarded by strict legal NDAs.
Bridging laboratory phytochemical discovery with high-volume industrial formulation across Seoul, Gyeonggi-do, and Chungcheong bio-clusters.
High-purity botanical actives optimized for transdermal delivery. Standardized Centella asiatica fractions (madecassoside, asiaticoside), polygonum bioactive resveratrol, and fermented camellia polyphenols with validated in vitro anti-elastase, anti-hyaluronidase, and cellular soothing indices.
Customized botanical formulations engineered to clear MFDS Individual Recognition approvals. Potency-verified active complexes targeting post-prandial glycemic control, cognitive function support, non-alcoholic fatty liver modulation, and deep joint mobility maintenance.
Translating classic Traditional Korean Medicine (Hanbang, 한방) and TCM formulas into modern evidence-based pharmaceuticals. High-yield extraction of classical decoctions with rigorous chromatographic fingerprinting and Phase I–IV clinical trial management support.
How our analytical and pharmacological teams systematically evaluate botanical raw materials to guarantee zero regulatory surprises.
Microscopic taxonomy verification, ITS2 / rbcL DNA barcoding authentication to definitively rule out adulterant species and closely related variants.
High-Performance Liquid Chromatography (HPLC-DAD-MS), GC-MS, and HPTLC fingerprint mapping. Quantification of characteristic active marker compounds.
ICP-MS heavy metal screen (Pb, Cd, As, Hg), GC-MS/MS 500+ multi-pesticide residue panel, residual solvent quantification (GC-FID), and pathogen testing.
Cellular viability assays, antioxidant capacity assays (ORAC, DPPH), receptor binding profiles, and preclinical in vivo metabolic verification.
ICH-compliant accelerated and real-time stability testing (temperature/humidity chambers) verifying degradation kinetic profiles across 24 months.
Submit your target botanical spec or active marker requirements for a complimentary study feasibility scope.
Send Inquiry NowComplete, end-to-end laboratory and CDMO services preserving all original technical endpoints, optimized for Korean enterprise sourcing.
Pinpoint the optimum harvest origin and harvest season to maximize active compound concentration and process efficiency.
ODM Potency Study →
High-throughput bioassays validating cellular mechanism of action, cytotoxicity thresholds, and functional pathways.
In Vitro Testing Service →
Comparative analytical audits identifying superior germplasms and ideal phenological harvest windows for consistent batch outputs.
Origin Evaluation ODM →
Controlled animal studies substantiating metabolic safety, organ bioavailability, and target functional benefits.
Animal Study Protocol →
Developing and validating HPTLC, HPLC-DAD, and GC assays for accurate quantification and regulatory filing in Korea.
Analytical Methods →
Rigorous GCP-compliant human clinical trials for dietary supplement substantiation and botanical drug NDA filings.
Clinical Trial Support →
Targeted screening of polysaccharides, alkaloids, and flavonoids to isolate key bioactive candidates for Korean brand projects.
Active Screening →
Bridging discovery to pilot scale-up and multi-ton finished dosage manufacturing (capsules, tablets, liquids) under GMP.
Explore Full CRO/CDMO →Direct answers addressing compliance, analytical documentation, non-disclosure protocols, and supply chain logistics.
Whether you require a multi-origin potency evaluation study, standardized extract supply for Korean MFDS dossiers, or pilot-to-commercial contract manufacturing, our team of 300+ scientists is ready to execute your brief.
